Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EPZ011989 is a effective, specific orally bioavailable EZH2 inhibitor with Ki < 3 nM for EZH2 Y646 and EZH2 wt; 15-fold selectivity over EZH1 and <3000-fold selectivity over other HMTase.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 35.00 | |
5 mg | In stock | $ 52.00 | |
10 mg | In stock | $ 76.00 | |
25 mg | In stock | $ 132.00 | |
50 mg | In stock | $ 213.00 | |
100 mg | In stock | $ 382.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 72.00 |
Description | EPZ011989 is a effective, specific orally bioavailable EZH2 inhibitor with Ki < 3 nM for EZH2 Y646 and EZH2 wt; 15-fold selectivity over EZH1 and >3000-fold selectivity over other HMTase. |
Targets&IC50 | EZH2:<3 nM(Ki), EZH1:103 nM |
Molecular Weight | 605.81 |
Formula | C35H51N5O4 |
CAS No. | 1598383-40-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
Ethanol: 100 mg/mL (155.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EPZ011989 1598383-40-4 Chromatin/Epigenetic Histone Methyltransferase inhibit Inhibitor EPZ 011989 EPZ-011989 inhibitor